Flagship Harbor Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Buy
1,703
+70
+4% +$12.9K 0.01% 616
2026
Q1
$308K Buy
1,633
+1,599
+4,703% +$337K 0.01% 588
2025
Q4
$6.76K Sell
34
-1,450
-98% -$293K ﹤0.01% 1599
2025
Q3
$301K Buy
1,484
+11
+0.7% +$1.95K 0.01% 628
2025
Q2
$259K Sell
1,473
-188
-11% -$28.3K 0.01% 649
2025
Q1
$223K Buy
1,661
+6
+0.4% +$790 0.01% 677
2024
Q4
$209K Buy
1,655
+285
+21% +$42.4K 0.01% 693
2024
Q3
$228K Buy
+1,370
New +$207K 0.01% 655

Other funds holding THC

Flagship Harbor Advisors's THC Position: Q2 2026 in Review

Flagship Harbor Advisors increased its Tenet Healthcare (THC) stake by 4.3% in Q2 2026, buying an estimated $12.9K and bringing the position to 1,703 shares worth $319K. The position accounts for 0.01% of the portfolio, ranked #616.

Flagship Harbor Advisors first reported a position in THC in Q3 2024 and has held it in 8 quarters since. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Flagship Harbor Advisors held 1,703 shares of Tenet Healthcare worth $319K as of Q2 2026.
  • Flagship Harbor Advisors bought 70 Tenet Healthcare shares in Q2 2026, an estimated $12.9K.
  • Tenet Healthcare made up 0.01% of Flagship Harbor Advisors's portfolio in Q2 2026, its #616 holding.
  • Flagship Harbor Advisors first reported a position in Tenet Healthcare in Q3 2024 and has held it in 8 quarters since.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.